GSP Crop Science Limited is an India-based agrochemical company engaged in the manufacturing, formulation, and marketing of crop protection products such as insecticides, herbicides, fungicides, and plant growth regulators. The company earns revenue through domestic sales and exports of agrochemical formulations and technical products used by farmers to protect crops from pests and diseases. Its products are widely used in agriculture for crops like cotton, rice, wheat, pulses, and vegetables, helping improve crop yield and productivity.


The Company is led by Promoter, i.e.,BHAVESH VRAJMOHAN SHAH, TIRTH KENAL SHAH, VILASBEN VRAJMOHAN SHAH, FALGUNI KENAL SHAH, ALPHA TRUST AND KAPPA TRUST

The Revenues frorom operations for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 8,476.08 Million, ₹ 13,010.56 Million, ₹ 11,582.28 Million, and ₹ 12,060.47 Million, The EBITDA for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 1,388.56 Million, ₹ 1,640.33 Million, ₹ 1,304.05 Million, and ₹ 812.82 Million, The Profit after Tax for the Period ended on Sep 30 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 810.65 Million, ₹ 814.20 Million, ₹ 555.40 Million, and ₹ 175.73 Million, respectively. This indicates a steady growth in financial performance.

 The Company Key Performance Indicates the pre-issue   EPS of   ₹ 21.38  and post-issue EPS of ₹ 17.50 for FY25. The pre-issue P/E ratio is 14.97x,while the post-issue P/E ratio is 18.28x against the Industry P/E ratio is 51.81x The company's ROE for FY25 is 18.38% and RoNW is 18.38% The Annualised EPS is ₹ 34.85x and P/E is ₹ 9.18x  , These metrics suggest that the IPO is Fully priced.

  
The Grey Market Premium (GMP) of GSP Crop Science showing listing gains of 0%.Given the company's financial performance and the valuation of the IPO, we recommend  Investors to Avoid to the GSP Crop Science Limited. IPO for Listing gain or Long Term Purposes.